New Antitrust Risks from Introducing New Drugs

When does withdrawing a product from the market and substituting with a newer version trigger antitrust scrutiny?  Learn about the latest “product hopping” cases from David Burns and Howard Morse (Cooley).

Read More (FDLI Members Only)
Become a FDLI Member